Related Experiment Video
Updated: Jun 17, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Canine paroxysmal dyskinesia-a review
Paul J J Mandigers1,2, Koen M Santifort1,2,3, Mark Lowrie4
1Department of Clinical Sciences, Expertise Centre of Genetics, Faculty of Veterinary Medicine, University of Utrecht, Utrecht, Netherlands.
Canine paroxysmal dyskinesias (PDs) are episodic involuntary movements. This review details their clinical types, causes, and management, aiding diagnosis and treatment for these hyperkinetic disorders in dogs.
Area of Science:
- Veterinary Neurology
- Movement Disorders
Background:
- Paroxysmal dyskinesias (PDs) are episodic, involuntary hyperkinetic movements without loss of consciousness.
- Canine PDs are clinically classified into paroxysmal kinesigenic dyskinesia (PKD), paroxysmal non-kinesigenic dyskinesia (PNKD), and paroxysmal exertion-induced dyskinesia (PED).
Purpose of the Study:
- To provide a comprehensive overview of reported canine paroxysmal dyskinesias.
- To emphasize phenotype, genotype, pathophysiology, and treatment for each type of canine PD.
Main Methods:
- Review of existing literature on canine paroxysmal dyskinesias.
- Clinical and etiological classification of canine PDs.
- Emphasis on video recording for phenomenological diagnosis.
Main Results:
- Detailed description of three main clinical types of canine PDs (PKD, PNKD, PED).
- Etiological classification includes genetic, reactive, structural, and unknown causes.
- Information on diagnosis, including phenomenology and video analysis.
Conclusions:
- Canine PDs are a diverse group of movement disorders requiring accurate classification.
- Understanding phenotype, genotype, and etiology is crucial for effective management.
- This review serves as a resource for diagnosing and treating canine PDs.
More Related Videos
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...